Content Analysis of FDA Warning Letters to Manufacturers of Pharmaceuticals and Therapeutic Biologicals for Promotional Violations Khalid M. KamalShane P. DesselleChristopher Zacker Regulatory Affairs 30 December 2009 Pages: 385 - 393
Electronic Common Technical Document Implementation in Japan Kiyohito NakaiYasuhiro ArakiSatoshi Toyoshima Regulatory Affairs 30 December 2009 Pages: 395 - 401
Editorial: Dealing with the Missing Data Challenge in Clinical Trials Thomas PermuttJosé Pinheiro Data Management — Missing Data 30 December 2009 Pages: 403 - 408
Incomplete Data in Clinical Studies: Analysis, Sensitivity, and Sensitivity Analysis Geert Molenberghs Data Management — Missing Data 30 December 2009 Pages: 409 - 429
Comment: Incomplete Data in Clinical Studies: Analysis, Sensitivity, and Sensitivity Analysis Joseph G. Ibrahim Data Management — Missing Data 30 December 2009 Pages: 431 - 432
A Commentary on G. Molenberghs’s Review of Missing Data Methods Eric J. Tchetgen Tchetgen Data Management — Missing Data 30 December 2009 Pages: 433 - 435
Discussion: “Incomplete Data in Clinical Studies: Analysis, Sensitivity, and Sensitivity Analysis” by Geert Molenberghs Paul A. Flyer Data Management — Missing Data 30 December 2009 Pages: 437 - 439
Global Sensitivity Analysis for Randomized Trials with Informative Dropout: A Semiparametric Perspective Daniel O. ScharfsteinAristide Achy-Brou Data Management — Missing Data 30 December 2009 Pages: 441 - 446
Incomplete Data in Clinical Studies: Analysis, Sensitivity, and Sensitivity Analysis—Rejoinder Geert Molenberghs Data Management — Missing Data 30 December 2009 Pages: 447 - 448
Conceptual Considerations regarding Endpoints, Hypotheses, and Analyses for Incomplete Longitudinal Clinical Trial Data Craig H. MallinckrodtMichael G. Kenward Data Management — Missing Data 30 December 2009 Pages: 449 - 458
Effective Strategies for Maintaining Research Participation in Clinical Trials Allen ZwebenLisa M. FucitoStephanie S. O’Malley Data Management — Missing Data 30 December 2009 Pages: 459 - 467
A Note on Missing Data in Noninferiority Trials Paul GalloChristy Chuang-Steiny Data Management — Missing Data 30 December 2009 Pages: 469 - 474
Sensitivity Analysis of Missing Data: Case Studies Using Model-Based Multiple Imputation Jie Zhang Data Management — Missing Data 30 December 2009 Pages: 475 - 484
Minimizing Missing Data in Clinical Trials: Design, Operation, and Regulatory Considerations Guoxing (Greg) Soon Data Management — Missing Data 30 December 2009 Pages: 485 - 492
Drug Development Portfolio and Spending Practices after Mergers and Acquisitions Kenneth A. GetzRachael ZuckermanKenneth I. Kaitin Drug Development: Continuing Education 30 December 2009 Pages: 493 - 500
Bringing Patient Recruitment into Our Digital World John D. McAnulty Drug Development 30 December 2009 Pages: 501 - 508
Assessing Medical Information Needs via an Internet-Based Survey Stacey M. FungLaura MerrimanMaureen Cawley Drug Information 30 December 2009 Pages: 509 - 518
2009 Annual Meeting Student Poster Abstracts Springer Annual Meeting 30 December 2009 Pages: 519 - 524